Bachem Holding AG (LON:0QND)

Market Cap	3.87B
Revenue (ttm)	622.20M
Net Income (ttm)	123.16M
Shares Out	n/a
EPS (ttm)	1.65
PE Ratio	31.43
Forward PE	28.37
Dividend	0.78 (1.39%)
Ex-Dividend Date	May 5, 2025

Volume	18,055
Average Volume	23,136
Open	55.95
Previous Close	56.10
Day's Range	54.80 - 55.95
52-Week Range	43.98 - 77.40
Beta	0.84
RSI	30.01
Earnings Date	Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,207
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF